C11orf42 | Chromosome 11 open reading frame 42 | | | | | | Tissue enriched |
PRKCDBP | Protein kinase C, delta binding protein | | | | | | Mixed |
APBB1 | Amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) | Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
HPX | Hemopexin | Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
ARFIP2 | ADP-ribosylation factor interacting protein 2 | Predicted secreted proteins
| | | | | Expressed in all |
RRP8 | Ribosomal RNA processing 8, methyltransferase, homolog (yeast) | | | | | | Expressed in all |
ILK | Integrin-linked kinase | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
TAF10 | TAF10 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 30kDa | | | | | | Expressed in all |
TPP1 | Tripeptidyl peptidase I | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
DCHS1 | Dachsous cadherin-related 1 | Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Mixed |
RBMXL2 | RNA binding motif protein, X-linked-like 2 | | | | | | Tissue enriched |
SYT9 | Synaptotagmin IX | Predicted membrane proteins
| | | | | Tissue enhanced |
PPFIBP2 | PTPRF interacting protein, binding protein 2 (liprin beta 2) | Plasma proteins
| | | | | Expressed in all |
CYB5R2 | Cytochrome b5 reductase 2 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
EIF3F | Eukaryotic translation initiation factor 3, subunit F | Enzymes Predicted secreted proteins
| | | | | Expressed in all |
RIC3 | RIC3 acetylcholine receptor chaperone | Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
TRIM66 | Tripartite motif containing 66 | | | | | | Mixed |
RPL27A | Ribosomal protein L27a | Ribosomal proteins
| | | | | Expressed in all |
AKIP1 | A kinase (PRKA) interacting protein 1 | | | | | | Expressed in all |
NRIP3 | Nuclear receptor interacting protein 3 | | | | | | Group enriched |
IPO7 | Importin 7 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
ZNF143 | Zinc finger protein 143 | Transcription factors
| | | | | Expressed in all |
WEE1 | WEE1 G2 checkpoint kinase | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
SWAP70 | SWAP switching B-cell complex 70kDa subunit | | | | | | Expressed in all |
AMPD3 | Adenosine monophosphate deaminase 3 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
LYVE1 | Lymphatic vessel endothelial hyaluronan receptor 1 | Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
MRVI1 | Murine retrovirus integration site 1 homolog | Predicted membrane proteins
| | | | | Mixed |
EIF4G2 | Eukaryotic translation initiation factor 4 gamma, 2 | Plasma proteins
| | | | | Expressed in all |
ZBED5 | Zinc finger, BED-type containing 5 | Transcription factors
| | | | | Expressed in all |
USP47 | Ubiquitin specific peptidase 47 | Enzymes
| | | | | Expressed in all |
DKK3 | Dickkopf WNT signaling pathway inhibitor 3 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
MICAL2 | Microtubule associated monooxygenase, calponin and LIM domain containing 2 | Cytoskeleton related proteins Predicted membrane proteins
| | | | | Expressed in all |
PARVA | Parvin, alpha | Plasma proteins Predicted membrane proteins
| | | | | Mixed |
TEAD1 | TEA domain family member 1 (SV40 transcriptional enhancer factor) | Disease related genes Transcription factors
| | | | | Mixed |
ARNTL | Aryl hydrocarbon receptor nuclear translocator-like | Predicted secreted proteins Transcription factors
| | | | | Expressed in all |
BTBD10 | BTB (POZ) domain containing 10 | | | | | | Expressed in all |
PTH | Parathyroid hormone | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Not detected |
RRAS2 | Related RAS viral (r-ras) oncogene homolog 2 | Disease related genes RAS pathway related proteins
| | | | | Expressed in all |
COPB1 | Coatomer protein complex, subunit beta 1 | Plasma proteins
| | | | | Expressed in all |
PSMA1 | Proteasome (prosome, macropain) subunit, alpha type, 1 | Enzymes
| | | | | Expressed in all |
PDE3B | Phosphodiesterase 3B, cGMP-inhibited | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
SOX6 | SRY (sex determining region Y)-box 6 | Transcription factors
| | | | | Mixed |
PLEKHA7 | Pleckstrin homology domain containing, family A member 7 | | | | | | Mixed |
NUCB2 | Nucleobindin 2 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
USH1C | Usher syndrome 1C (autosomal recessive, severe) | Cancer-related genes Cytoskeleton related proteins Disease related genes
| | | | | Group enriched |
MYOD1 | Myogenic differentiation 1 | Cancer-related genes Transcription factors
| | | | | Tissue enriched |
KCNC1 | Potassium voltage-gated channel, Shaw-related subfamily, member 1 | FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |
SERGEF | Secretion regulating guanine nucleotide exchange factor | | | | | | Expressed in all |
TPH1 | Tryptophan hydroxylase 1 | Enzymes FDA approved drug targets
| | | | | Group enriched |
SAAL1 | Serum amyloid A-like 1 | | | | | | Expressed in all |